Vaccines

Providing paid time off to employees to get and recover from any side effects could help boost vaccination rates. Overall, nearly three in ten (28%) employed adults who not yet ready to get the vaccine say that they would be more likely to get the COVID-19 vaccine if their employer gave them paid time off to get vaccinated and recover from any side effects.

This analysis uses CDC data to look at vaccination rates for adults 65 and older. The findings show that vaccination rates vary by county and that adults ages 65 and older are less likely to be fully vaccinated in counties in the South, in counties where a higher share of older adults live in poverty, and in counties that voted for Trump.

Before the FDA expanded the Pfizer-BioNTech COVID-19 vaccine emergency use authorization for 12 to 15 year olds this week, the latest KFF COVID-19 Vaccine Monitor reported that 30 percent of parents of children ages 12 to 15 said they would get their child vaccinated right away.

This issue brief builds on a previous CDC analysis by analyzing how vaccination rates to date vary by counties and identifying key county characteristics that are associated with higher or lower county vaccination rates.

This post examines characteristics of adolescents ages 12 to 15 across in the United States to inform COVID-19 vaccination efforts once they become eligible to receive a vaccine.

As of April 19, COVID-19 vaccine eligibility opened up to adults in all states, leaving many to wonder when supply will surpass vaccine demand. A recent brief examined when COVID-19 vaccine supply might outstrip demand in the U.S. nationally, estimating that the U.S. will reach this point within a few…

This analysis examines overall COVID-19 vaccination levels and how the rate of vaccinations over the last week has changed at state-level and national level. There is significant variability by state in how many adults in the US have been vaccinated with at least one dose. Most states are also seeing a decline in the pace of vaccinations, indicating that they may be approaching the point when vaccine supply exceeds demand.

As India and other countries continue to grapple with major COVID-19 outbreaks even as cases decline in this country, there is increasing attention to the global role that could be played by the U.S. government.  This is particularly the case now that the U.S. will soon have enough COVID-19 vaccine…

This brief examines U.S. policy options for helping expand global access to COVID-19 vaccines, focusing on four main areas: in-kind donations of vaccine doses, additional funding for global access mechanisms like COVAX, helping expand global vaccine manufacturing, and relaxing or waiving intellectual property protections on vaccine technologies. We summarize what the administration has done to date in these areas and policy issues related to each.

Staffing to administer the COVID-19 vaccines is now the most common challenge for community health centers’ vaccination programs, overtaking the previously reported vaccine supply challenges.